Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.

Huang J, Lo UG, Wu S, Wang B, Pong RC, Lai CH, Lin H, He D, Hsieh JT, Wu K.

Cell Death Dis. 2019 Jun 4;10(6):437. doi: 10.1038/s41419-019-1669-z.

2.

Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.

Lee CF, Dang A, Hernandez E, Pong RC, Chen B, Sonavane R, Raj G, Kapur P, Lin HY, Wu SR, Ko CJ, Lo UG, Lee HY, Hsieh JT, Lee MS.

Oncogene. 2019 May 31. doi: 10.1038/s41388-019-0833-3. [Epub ahead of print]

PMID:
31152147
3.

Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.

Lo UG, Bao J, Cen J, Yeh HC, Luo J, Tan W, Hsieh JT.

Am J Clin Exp Urol. 2019 Feb 18;7(1):31-45. eCollection 2019.

4.

Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.

Chen YA, Tzeng DTW, Huang YP, Lin CJ, Lo UG, Wu CL, Lin H, Hsieh JT, Tang CH, Lai CH.

Cancers (Basel). 2018 Dec 31;11(1). pii: E34. doi: 10.3390/cancers11010034.

5.

IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.

Lo UG, Pong RC, Yang D, Gandee L, Hernandez E, Dang A, Lin CJ, Santoyo J, Ma S, Sonavane R, Huang J, Tseng SF, Moro L, Arbini AA, Kapur P, Raj GV, He D, Lai CH, Lin H, Hsieh JT.

Cancer Res. 2019 Mar 15;79(6):1098-1112. doi: 10.1158/0008-5472.CAN-18-2207. Epub 2018 Nov 30.

PMID:
30504123
6.

The regulatory pathways leading to stem-like cells underlie prostate cancer progression.

Lin CJ, Lo UG, Hsieh JT.

Asian J Androl. 2019 May-Jun;21(3):233-240. doi: 10.4103/aja.aja_72_18.

7.

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression.

Lo UG, Lee CF, Lee MS, Hsieh JT.

Int J Mol Sci. 2017 Sep 30;18(10). pii: E2079. doi: 10.3390/ijms18102079. Review.

8.

Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer.

Wang B, Lo UG, Wu K, Kapur P, Liu X, Huang J, Chen W, Hernandez E, Santoyo J, Ma SH, Pong RC, He D, Cheng YQ, Hsieh JT.

Int J Cancer. 2017 Nov 15;141(10):2121-2130. doi: 10.1002/ijc.30893. Epub 2017 Jul 31.

9.

Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy.

Lin HJ, Liu HH, Lin CD, Kao MC, Chen YA, Chiang-Ni C, Jiang ZP, Huang MZ, Lin CJ, Lo UG, Lin LC, Lai CK, Lin H, Hsieh JT, Chiu CH, Lai CH.

Front Cell Infect Microbiol. 2017 Jun 8;7:223. doi: 10.3389/fcimb.2017.00223. eCollection 2017.

10.

Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems.

Chen YA, Lien HM, Kao MC, Lo UG, Lin LC, Lin CJ, Chang SJ, Chen CC, Hsieh JT, Lin H, Tang CH, Lai CH.

PLoS One. 2017 Jan 12;12(1):e0169204. doi: 10.1371/journal.pone.0169204. eCollection 2017.

11.

Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy.

Huang WY, Lin JN, Hsieh JT, Chou SC, Lai CH, Yun EJ, Lo UG, Pong RC, Lin JH, Lin YH.

ACS Appl Mater Interfaces. 2016 Nov 16;8(45):30722-30734. Epub 2016 Nov 7.

PMID:
27786455
12.

The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.

Yun EJ, Lo UG, Hsieh JT.

Asian J Urol. 2016 Oct;3(4):203-210. doi: 10.1016/j.ajur.2016.09.006. Epub 2016 Sep 20. Review.

13.

Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin.

Lai CK, Chen YA, Lin CJ, Lin HJ, Kao MC, Huang MZ, Lin YH, Chiang-Ni C, Chen CJ, Lo UG, Lin LC, Lin H, Hsieh JT, Lai CH.

Front Cell Infect Microbiol. 2016 Feb 9;6:9. doi: 10.3389/fcimb.2016.00009. eCollection 2016. Review.

14.

Impact of cholesterol on disease progression.

Lin CJ, Lai CK, Kao MC, Wu LT, Lo UG, Lin LC, Chen YA, Lin H, Hsieh JT, Lai CH, Lin CD.

Biomedicine (Taipei). 2015 Jun;5(2):7. doi: 10.7603/s40681-015-0007-8. Epub 2015 Jun 1.

15.

p38α (MAPK14) critically regulates the immunological response and the production of specific cytokines and chemokines in astrocytes.

Lo U, Selvaraj V, Plane JM, Chechneva OV, Otsu K, Deng W.

Sci Rep. 2014 Dec 12;4:7405. doi: 10.1038/srep07405.

16.

The role of microRNAs in prostate cancer progression.

Lo UG, Yang D, Hsieh JT.

Transl Androl Urol. 2013 Sep;2(3):228-41. doi: 10.3978/j.issn.2223-4683.2013.08.01. Review.

17.

Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination.

Soundarapandian MM, Selvaraj V, Lo UG, Golub MS, Feldman DH, Pleasure DE, Deng W.

Sci Rep. 2011;1:2. doi: 10.1038/srep00002. Epub 2011 Jun 14.

18.

Differentiating human stem cells into neurons and glial cells for neural repair.

Selvaraj V, Jiang P, Chechneva O, Lo UG, Deng W.

Front Biosci (Landmark Ed). 2012 Jan 1;17:65-89. Review.

PMID:
22201733

Supplemental Content

Support Center